← Study Library
Review · 2017
Preclinicalcounts toward this tierMethylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement
Butawan M, Benjamin RL, Bloomer RJ · Nutrients
Preclinicalcounts toward this tier
Summarizes evidence that MSM dampens NF-kB signalling and oxidative stress in preclinical models and is well tolerated in humans (GRAS status; trials up to ~6 g/day report adverse events comparable to placebo).
- Population
- Narrative review of MSM pharmacology, mechanisms, and safety
- Intervention
- MSM at doses up to about 4 g/day in humans; mechanistic data from cell and animal models
- Comparator
- n/a
- Limitations
- Narrative review; mechanistic claims rest largely on in-vitro and animal data.
Cited by
1 entry references this study
- MSM (methylsulfonylmethane)PROM.
Supplements → Anti-inflammatories